『The James Altucher Show』のカバーアート

The James Altucher Show

The James Altucher Show

著者： James Altucher
無料で聴く

James Altucher interviews the world's leading peak performers in every area of life. But instead of giving you the typical success story, James digs deeper to find the "Choose Yourself" story - these are the moments we relate to... when someone rises up from personal struggle to reinvent themselves. The James Altucher Show brings you into the lives of peak-performers: billionaires, best-selling authors, rappers, astronauts, athletes, comedians, actors, and the world champions in every field, all who forged their own paths, found financial freedom and harnessed the power to create more meaningful and fulfilling lives.© Copyright © 2002-2025 PodcastOne.com. All rights reserved. 経済学
エピソード
  • Frank Miller on Push the Wall, Batman, and Having No Plan B

    Frank Miller on Push the Wall, Batman, and Having No Plan B
    2026/07/08
    A Note from James:This is a very special episode for me.There have only been a few times in the history of this podcast when I’ve had the chance to sit down with one of my heroes. This is one of those times.Frank Miller is one of the most important storytellers of my life. When I first picked up Batman: The Dark Knight Returns in 1986, it completely changed what I thought comics could be. This wasn’t just another Batman story. It was a revolution. Frank took Batman out of the colorful, campy world I grew up with and turned him into something darker, mythic, terrifying, and psychologically real.There is a comic book industry before The Dark Knight Returns, and there is a comic book industry after The Dark Knight Returns. Every Batman movie since then carries Frank’s fingerprints in some way. But it wasn’t just Batman. Frank changed Daredevil. He created Ronin. He created Sin City. He showed that comics could handle adult stories, painful arcs, crime, tragedy, mythology, obsession, and moral ambiguity.But what matters most to me is that Frank is a master storyteller. And I love storytelling. Whether it’s books, podcasts, articles, comics, or just how we make sense of our lives, story is everything.So getting to sit down with Frank Miller and talk about Batman, myth, creativity, mentorship, discipline, and his new book, Push the Wall: My Life, Writing, Drawing, and the Art of Storytelling, was a dream come true.This was my first in-person podcast in years. Jay drove up from Atlanta. I flew into the city. And yes, I brought my copy of The Dark Knight Returns for Frank to sign.Episode Description:Frank Miller didn’t just write and draw some of the most influential comics of the modern era. He changed the grammar of comics.In this conversation, James sits down with Miller to talk about Batman: The Dark Knight Returns, Daredevil, Ronin, Sin City, and Miller’s new book, Push the Wall. The conversation begins with Batman, but quickly becomes a larger discussion about how characters become myths.For Miller, Batman was never just a rich detective in a costume. The material was already there from the beginning: a child witnessing the murder of his parents, growing up without powers, building himself into a force through discipline, intelligence, and obsession. Miller’s goal was to pull that core truth out and make Batman stand beside older pulp and mythic figures like Zorro, The Shadow, and the hard-edged heroes of crime cinema.James and Frank also talk about how myths are built around simple central values. Superman is hope. Batman is justice, vengeance, effort, and fear. The art is not in making those ideas complicated. The art is in placing them inside a human context so they feel emotionally true.The discussion moves into the craft of comics itself: page layouts, panel borders, visual rhythm, and how the pictures carry most of the story. Miller reflects on the influence of Jack Kirby, Neal Adams, Denny O’Neil, Japanese samurai films, martial arts movies, Greek tragedy, Jean Giraud/Moebius, Lone Wolf and Cub, and the creative power of combining worlds that do not obviously belong together.They also talk about mentorship. Miller describes calling Neal Adams from the phone book, bringing him drawings, and enduring brutally honest criticism. That toughness, he says, was part of the training. To survive as an artist, you need egoism without egotism: enough belief to keep coming back, but enough humility to keep learning.The episode closes with practical advice for young artists today: go to conventions, build the strongest portfolio you can, seek out hard criticism, don’t chase only the biggest titles, protect your original ideas, and look for “losers” you can make great.What You’ll Learn:Why Frank Miller wanted Batman to become a myth, not just another superhero.How The Dark Knight Returns helped move comics toward darker, more adult storytelling.Why Batman’s lack of superpowers is exactly what makes him compelling.How mythic characters are built around simple core themes like hope, vengeance, justice, or discipline.Why comics are not just written stories with pictures, but a visual storytelling machine.How Miller learned from Jack Kirby, Neal Adams, Denny O’Neil, samurai films, noir, Greek tragedy, and European comics.Why creativity often comes from combining unrelated influences.What Miller means by “egoism, but not egotism.”Why young artists should seek out hard lessons instead of easy praise.How to enter comics today without giving away original work too early.Why determination, stamina, and a lack of Plan B shaped Miller’s career.What Miller is working on next, including a new Western-style Sin City story.Timestamped Chapters:[03:41] Meeting Frank MillerJames begins by holding up Batman: The Dark Knight Returns and asking what it means to be known through one defining work.[04:00] Before and After The Dark Knight ReturnsWhy James sees Miller’s Batman as a dividing line in...
    続きを読む 一部表示
    41 分
  • Dr. David Sinclair: The First Human Trial of an Age-Reversal Therapy

    Dr. David Sinclair: The First Human Trial of an Age-Reversal Therapy
    2026/07/03
    A Note from James:I’ve been obsessed with anti-aging and longevity science for a long time. I’ve had many longevity researchers on the podcast, but this episode feels different because something we’ve been discussing for years has now moved into human trials.David Sinclair first came on the show in 2019, when his book Lifespan was published. He’s a professor of genetics at Harvard Medical School, and that first conversation changed how I lived. I started experimenting with intermittent fasting, paid much more attention to sleep, and began researching many of the supplements and lifestyle changes he discussed.But the most important idea David talked about wasn’t a supplement. It was the possibility of reversing cellular age using Yamanaka factors—genes that can reset the instructions cells use to function. At the time, nobody knew whether this could be done safely without causing cancer or making cells lose their identities.Now, a therapy based on three of those factors has entered its first human clinical trial. The initial target is age-related damage to the optic nerve, including open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy. The trial is designed primarily to evaluate safety, but researchers will also measure visual function.David explains how this technology worked in mice and nonhuman primates, why the eye was chosen as the first organ, and how the same approach might eventually be applied to the liver, lungs, joints, skin, and brain.We also cover the practical questions people always ask him: NMN, NAD, metformin, berberine, testosterone, growth hormone, diet, fasting, sleep, exercise, and what David himself has started—or stopped—taking.This is still experimental science. Nobody yet knows whether the animal results will translate into meaningful benefits for humans. But for the first time, researchers are beginning to test that question directly.About Lifespan: Dr. David Sinclair founded Lifespan to deliver clear, science-backed health insights that help people live longer, more vibrant lives.He's now building the world's largest community dedicated to extending human longevity well beyond today’s limits. Join early access at lifespan.com. New episodes of Lifespan with Dr. David Sinclair -- the #1 health and wellness podcast in its first season -- are now available on YouTube, Spotify, Apple Podcasts, and Lifespan.com.Episode Description:For years, longevity researchers have looked for ways to slow the biological processes associated with aging. Dr. David Sinclair and his collaborators are now testing a more ambitious possibility: whether damaged human cells can be restored to a younger, more functional state.The experimental therapy, ER-100, uses controlled expression of three transcription factors—OCT4, SOX2, and KLF4, collectively known as OSK. These are three of the four Yamanaka factors originally used to transform adult cells into pluripotent stem cells.Turning on all four factors can erase too much of a cell’s identity and has produced tumors and fatal outcomes in animal experiments. Sinclair’s team found that removing one factor, c-MYC, allowed cells to regain younger patterns of gene expression without completely returning to a stem-cell state.In preclinical studies, OSK restored youthful epigenetic patterns, promoted optic-nerve regeneration, and reversed vision loss in mouse models. Life Biosciences, a company Sinclair co-founded, has now moved the technology into a first-in-human Phase 1 trial involving people with open-angle glaucoma or non-arteritic anterior ischemic optic neuropathy.David explains how the therapy is delivered directly into the eye and activated using doxycycline, allowing clinicians to control when and for how long the genes are expressed. He also describes the development path that could follow if the treatment proves safe, including therapies targeting the liver and other organs, as well as future medicines that may reproduce similar effects without gene delivery.The conversation then turns to interventions available today. David distinguishes between promising research and claims that have moved ahead of the evidence, discussing NMN, injected NAD, growth hormone, testosterone, taurine, nattokinase, metformin, berberine, and nootropics.Throughout the episode, he emphasizes that no supplement has been shown to reproduce the effects researchers are attempting to achieve through partial epigenetic reprogramming—and that many of the most dramatic claims circulating online remain unsupported.Editorial Note:ER-100 is an investigational therapy. Authorization to begin a clinical trial does not mean the treatment has been proven safe or effective, nor has it been approved for clinical use.The Phase 1 study is primarily evaluating safety and tolerability, with additional measurements of visual function. Results from mice and nonhuman primates do not establish that the therapy will restore vision or reverse biological ...
    続きを読む 一部表示
    49 分
  • How to Find Sure Things on Kalshi | Prediction Markets #1

    How to Find Sure Things on Kalshi | Prediction Markets #1
    2026/06/26
    Episode Description:Prediction markets allow people to trade contracts tied to real-world events—from elections and weather to rocket launches, airport traffic, awards, and the words a public figure might use during a speech.But James argues that having an opinion isn’t enough. Betting on your favorite team, preferred candidate, or a vague feeling about what might happen is speculation without an edge. His rule is simple: only participate when you believe you have an unfair advantage.In this solo episode, James explains the two advantages he looks for. The first comes from understanding how prediction-market participants behave—especially their tendency to overlook outcomes that appear almost certain because the potential payout looks small. The second comes from researching a particular market more thoroughly than the other participants.He walks through three trades he made: whether the U.S. government will confirm the existence of extraterrestrial life before 2027, whether SpaceX will exceed a specified number of June launches, and whether Donald Trump will use the phrase “movie star” during an upcoming speech. He also examines TSA passenger data to show why good research sometimes leads to the most important decision of all: not making the trade.The larger lesson is not that any outcome is guaranteed. It is that a repeatable process—researching the data, comparing your estimated probability with the market price, diversifying, and walking away when the edge is unclear—is more useful than betting on instinct.Editorial Note:Prediction-market contracts are speculative and can result in the loss of the full amount committed to a position. Short-term returns expressed on an annualized basis are hypothetical comparisons, not guarantees that the same opportunity can be repeated throughout a year. This episode is educational and reflects James’s personal reasoning, not individualized financial advice.What You’ll Learn:How binary prediction-market contracts are priced and settled.Why James avoids trades based only on personal preference or intuition.The two types of informational advantage he looks for before entering a market.Why apparently likely outcomes can still be priced below James’s estimate of their probability.How to compare a contract’s price with your independent estimate of the outcome.Why diversification matters when a single losing contract can erase several smaller gains.How historical speeches, launch schedules, and public datasets can inform a trade.Why declining to place a bet is often the correct conclusion when the evidence is inconclusive.Timestamped Chapters:[02:00] The Search for an Unfair AdvantageWhy James believes a feeling or personal preference is not a sufficient reason to place a bet.[02:43] What Is a Prediction Market?How event contracts cover subjects ranging from weather and elections to entertainment, sports, and public speeches.[03:29] How Yes-or-No Contracts WorkA hypothetical presidential contract illustrates pricing, payouts, and profit.[04:26] Don’t Bet on What You Want to HappenWhy fandom, political preference, and intuition can distort judgment.[05:12] Two Types of Informational AdvantageJames distinguishes between understanding market behavior and possessing unusually strong research about one event.[06:30] Why Traders May Overlook Near-CertaintiesHow small-looking payouts and the cost of tying up capital can leave heavily favored outcomes below full value.[07:52] Will the Government Confirm That Aliens Exist?James explains why he bought “No” contracts on an official confirmation occurring before 2027.[10:40] Diversifying a Basket of High-Probability TradesWhy James prefers multiple positions rather than concentrating everything in one supposedly certain outcome.[11:20] The SpaceX Launch TradeUsing completed launches, the remaining calendar, and an upcoming mission to evaluate a five-day contract.[13:38] Turning Presidential Speeches Into DataHow James analyzes recurring words and phrases instead of relying on opinions about Donald Trump.[15:38] Betting Against “Movie Star”Why past speeches, synonyms, context, and the market price led James to take the “No” side.[18:30] TSA Passenger Data—and Knowing When to PassHistorical checkpoint volume offers useful evidence, but not necessarily enough of an edge to justify a trade.[21:01] Three Trades and One Repeatable SystemJames reviews his positions and the difference between market-level and event-specific advantages.[23:00] Prediction Markets as a Continuing ExperimentWhy James plans to keep testing the approach and sharing shorter updates.Additional Resources:Kalshi: What Are Prediction Markets? — An introduction to event contracts, pricing, and settlement.Kalshi: How Prices Are Determined — How opposing orders are matched and market prices are established.Kalshi FAQ — Platform rules, prohibited conduct, trading mechanics, and account information.CFTC: Understanding Prediction...
    続きを読む 一部表示
    22 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません